天宇股份(300702.SZ):甲苯磺酸艾多沙班片藥品獲得批準
格隆匯3月14日丨天宇股份(300702.SZ)公佈,全資子公司浙江諾得藥業有限公司於近日收到國家藥品監督管理局覈準簽發的關於甲苯磺酸艾多沙班片的《藥品註冊證書》。甲苯磺酸艾多沙班片適應症爲:1.用於伴有一個或多個風險因素(如充血性心力衰竭、高血壓、年齡≥75歲、糖尿病、既往卒中或短暫性腦缺血發作(TIA)病史)的非瓣膜性房顫(NVAF)成人患者,預防卒中和體循環栓塞。2.用於治療成人深靜脈血栓(DVT)和肺栓塞(PE),以及預防成人深靜脈血栓和肺栓塞復發。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.